A detailed history of American Portfolios Advisors transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 4,500 shares of ATRA stock, worth $54,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,500
Holding current value
$54,900
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$2.85 - $8.73 $12,825 - $39,285
4,500 New
4,500 $17 Million
Q2 2022

Mar 20, 2023

BUY
$4.69 - $9.84 $20,401 - $42,804
4,350 Added 96.67%
8,850 $68.9 Million
Q1 2022

Mar 21, 2023

BUY
$8.44 - $16.89 $36,714 - $73,471
4,350 Added 96.67%
8,850 $82.2 Million
Q4 2021

Mar 21, 2023

BUY
$14.7 - $19.89 $60,270 - $81,549
4,100 Added 91.11%
8,600 $136 Million
Q3 2021

Mar 22, 2023

BUY
$11.99 - $17.9 $55,154 - $82,340
4,600 Added 102.22%
9,100 $163 Million
Q2 2021

Mar 22, 2023

SELL
$12.89 - $16.58 $17,723 - $22,797
-1,375 Reduced 30.56%
3,125 $48.6 Million
Q1 2021

Mar 22, 2023

SELL
$14.0 - $20.72 $39,900 - $59,052
-2,850 Reduced 63.33%
1,650 $23.7 Million
Q4 2020

Mar 22, 2023

SELL
$12.67 - $26.23 $42,761 - $88,526
-3,375 Reduced 75.0%
1,125 $22.1 Million

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.15B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.